Bio‐equivalence of Potency Adjusted Approved Heparin Solutions Compared to a Newly Developed Heparin Solution.

MLA

Hoppensteadt, Debra, et al. “Bio‐equivalence of Potency Adjusted Approved Heparin Solutions Compared to a Newly Developed Heparin Solution.” FASEB Journal, vol. 36, May 2022, p. N.PAG. EBSCOhost, https://doi.org/10.1096/fasebj.2022.36.S1.R4995.

APA

Hoppensteadt, D., Jeske, W., Farooqui, A., Kouta, A., Iqbal, O., Kantarcioglu, B., Kraemer, R., Bansal, V., & Fareed, J. (2022). Bio‐equivalence of Potency Adjusted Approved Heparin Solutions Compared to a Newly Developed Heparin Solution. FASEB Journal, 36, N.PAG. https://doi.org/10.1096/fasebj.2022.36.S1.R4995

Chicago

Hoppensteadt, Debra, Walter Jeske, Ambar Farooqui, Ahmed Kouta, Omer Iqbal, Bulent Kantarcioglu, Roland Kraemer, Vinod Bansal, and Jawed Fareed. 2022. “Bio‐equivalence of Potency Adjusted Approved Heparin Solutions Compared to a Newly Developed Heparin Solution.” FASEB Journal 36 (May): N.PAG. doi:10.1096/fasebj.2022.36.S1.R4995.